Ramford K Ng, MD
Cardiovascular Disease (Cardiology) · Pleasanton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Offices
- 2
Offices
2 locations · University Healthcare Alliance · Stanford Health Care
Hospitals listed: Mercy Medical Center · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ng’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A90330 · Current
Licensed to practise in California · since 2005 · expires 2027-03-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mercy Medical CenterMerced, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.364, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Mercy Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.364 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.1 (0.11 to 2.09) · 798 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.74 (0.37 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 449 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.5 · 544 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 206 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,843 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,594 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 5,647 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.53 (0.28 to 4.78) · 763 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.96 (0.37 to 3.55) · 791 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.67 (0 to 16.88) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.84 (0.67 to 9.02) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.92 (0.46 to 3.38) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,979 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.764 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 31 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 477 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 62.8 · 511 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 43.6 · 554 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 462 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.8 to 8.2) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (8 to 14.1) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.2 to 19) · 70 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 413 cases | No different | Jan 2024 – Dec 2024 |
What patients said (394 patients answered, 11% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$736,039
Medicare paid this office $736,039 for 2,638 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 695 | $121,480 | $113 |
| Short return visit (20+ min) | 803 | $89,840 | $79 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 438 | $75,823 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 207 | $50,339 | $104 |
| Critical care, first 30-74 minutes | 101 | $43,880 | $181 |
See all 52 services
| Return visit (30+ min) | 695 | $121,480 | $113 |
| Short return visit (20+ min) | 803 | $89,840 | $79 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 438 | $75,823 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 207 | $50,339 | $104 |
| Critical care, first 30-74 minutes | 101 | $43,880 | $181 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 533 | $32,091 | $58 |
| Long return visit (40+ min) | 164 | $31,796 | $156 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 156 | $30,775 | $192 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 190 | $28,943 | $140 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 54 | $28,706 | $422 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 34 | $19,705 | $106 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 813 | $16,476 | $15 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 35 | $15,247 | $436 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 100 | $13,361 | $54 |
| Programming of dual lead pacemaker system | 122 | $12,000 | $74 |
| Replacement of aortic valve through the skin and femoral artery | 14 | $8,573 | $612 |
| New patient visit (30+ min) | 89 | $8,397 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 791 | $8,308 | $7 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 15 | $7,936 | $529 |
| New patient visit (45+ min) | 55 | $7,929 | $144 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 142 | $7,246 | $24 |
| Removal and replacement of dual lead permanent pacemaker | 21 | $6,451 | $307 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 190 | $4,541 | $22 |
| New patient visit (60+ min) | 19 | $3,638 | $191 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 216 | $3,481 | $14 |
| External shock to heart to regulate heart beat | 29 | $3,302 | $94 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 15 | $3,100 | $194 |
| Ultrasound of heart, follow-up | 105 | $2,934 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 236 | $2,698 | $10 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $2,423 | $220 |
| Programming of single lead pacemaker system | 27 | $2,289 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 189 | $2,236 | $12 |
| Programming of multiple lead implantable defibrillator system | 13 | $2,136 | $102 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $2,039 | $82 |
| Programming of dual lead implantable defibrillator system | 12 | $1,973 | $90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 222 | $1,852 | $7 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 31 | $1,839 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,601 | $70 |
| Return visit (30+ min) | 19 | $1,471 | $77 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,207 | $93 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 25 | $1,161 | $30 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 20 | $1,093 | $55 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 42 | $927 | $22 |
| Programming of dual lead pacemaker system | 26 | $853 | $33 |
| Insertion of heart rhythm monitor under skin | 11 | $802 | $73 |
| Heart rhythm recording of continous external ekg over 8-15 days | 54 | $714 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 89 | $658 | $6 |
| Programming of single lead pacemaker system | 11 | $302 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 16 | $282 | $18 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $224 | $20 |
| Ultrasonic guidance for blood vessel access | 13 | $153 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $60 | $3 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 96 | More than 95% of doctors who do this |
| Pacemaker insertion or repair | 50 | More than 89% of doctors who do this |
Who their Medicare patients are
2,638 Original Medicare patients in 2024. Average age 77 · Under 65 5% · 85 and older 22% · Women 53% · Also on Medicaid 24% · Health risk score 1.79. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 48% · Chronic kidney disease 45% · Atrial fibrillation 37% · Diabetes 35% · Heart failure 34% · Depression 23% · Cancer 21% · COPD 21% · Stroke 15% · Dementia 14%.
The office billed $5,863,570, Medicare allowed $967,683 and paid $736,039; for 10,187 services of 86 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,638 | 10,187 | 77 | 1.79 | $5,863,570 | $736,039 |
| 2023 | 2,369 | 9,111 | 77 | 1.74 | $5,168,913 | $642,610 |
| 2022 | 2,090 | 8,121 | 77 | 1.69 | $3,369,599 | $589,962 |
| 2021 | 1,827 | 8,018 | 77 | 1.73 | $3,057,389 | $611,139 |
| 2020 | 1,502 | 6,980 | 77 | 1.96 | $3,043,765 | $536,024 |
| 2019 | 1,712 | 7,145 | 77 | 1.88 | $2,638,497 | $519,168 |
| 2018 | 1,462 | 5,477 | 77 | 1.86 | $1,810,281 | $377,055 |
| 2017 | 1,434 | 5,171 | 77 | 1.81 | $1,574,535 | $355,667 |
| 2016 | 1,324 | 4,277 | 77 | 1.91 | $1,310,528 | $304,477 |
| 2015 | 1,303 | 4,365 | 77 | 1.90 | $1,033,938 | $282,395 |
| 2014 | 1,295 | 4,491 | 76 | 1.72 | $846,833 | $291,596 |
| 2013 | 1,278 | 3,970 | 76 | 1.79 | $706,482 | $252,324 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 45 services
| Return visit (30+ min) | 576 | $101,561 | $113 |
| Short return visit (20+ min) | 818 | $97,809 | $77 |
| Critical care, first 30-74 minutes | 121 | $55,835 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 228 | $54,647 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 232 | $38,363 | $148 |
| Long return visit (40+ min) | 151 | $29,251 | $156 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 442 | $26,819 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 437 | $25,427 | $55 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 118 | $24,343 | $206 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 38 | $19,622 | $427 |
| Programming of dual lead pacemaker system | 114 | $12,094 | $77 |
| Replacement of aortic valve through the skin and femoral artery | 18 | $11,134 | $619 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 23 | $10,173 | $442 |
| New patient visit (45+ min) | 66 | $9,180 | $139 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 811 | $8,506 | $7 |
| Telehealth originating site facility fee | 287 | $7,646 | $21 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 76 | $7,208 | $20 |
| New patient visit (60+ min) | 34 | $6,590 | $194 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 91 | $6,357 | $70 |
| Insertion of permanent leadless pacemaker using imaging guidance | 17 | $6,267 | $369 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 119 | $6,064 | $24 |
| New patient visit (30+ min) | 53 | $5,304 | $100 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 32 | $4,250 | $21 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 165 | $3,684 | $22 |
| External shock to heart to regulate heart beat | 31 | $3,485 | $97 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 16 | $2,757 | $172 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 147 | $2,320 | $13 |
| Programming of single lead pacemaker system | 25 | $2,255 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,245 | $70 |
| Ultrasound of heart, follow-up | 85 | $2,110 | $22 |
| Programming of multiple lead implantable defibrillator system | 12 | $1,893 | $95 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 220 | $1,875 | $7 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 25 | $1,565 | $60 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 140 | $1,562 | $11 |
| Return visit (30+ min) | 14 | $1,215 | $87 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 19 | $1,157 | $61 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 50 | $945 | $19 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 18 | $916 | $31 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 148 | $751 | $5 |
| Programming of dual lead pacemaker system | 19 | $633 | $33 |
| Short return visit | 12 | $544 | $45 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 75 | $506 | $6 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $423 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 25 | $310 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $88 | $8 |
2022: 45 services
| Short return visit (20+ min) | 765 | $101,113 | $77 |
| Return visit (30+ min) | 418 | $81,730 | $114 |
| Critical care, first 30-74 minutes | 121 | $61,388 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 215 | $49,773 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 275 | $39,141 | $137 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 520 | $32,772 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 154 | $27,849 | $168 |
| Long return visit (40+ min) | 119 | $25,365 | $171 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 93 | $19,187 | $206 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 32 | $16,770 | $453 |
| New patient visit (45+ min) | 74 | $11,422 | $154 |
| Programming of dual lead pacemaker system | 93 | $10,068 | $78 |
| New patient visit (30+ min) | 78 | $7,658 | $98 |
| New patient visit (60+ min) | 36 | $7,434 | $207 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 729 | $7,369 | $7 |
| Initial hospital observation care per day, typically 70 minutes | 45 | $6,697 | $149 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 102 | $6,157 | $26 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 79 | $5,737 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 75 | $4,091 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 244 | $3,751 | $13 |
| Telehealth originating site facility fee | 146 | $3,628 | $22 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 19 | $3,526 | $186 |
| External shock to heart to regulate heart beat | 27 | $3,100 | $94 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 30 | $2,593 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,204 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 181 | $2,188 | $12 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 83 | $1,890 | $22 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 17 | $1,632 | $33 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,630 | $71 |
| Ultrasound of heart, follow-up | 62 | $1,599 | $21 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 21 | $1,549 | $74 |
| Programming of single lead pacemaker system | 16 | $1,525 | $69 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 20 | $1,288 | $61 |
| Follow-up observation care per day, typically 35 minutes | 13 | $1,255 | $84 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,153 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 132 | $995 | $7 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 164 | $840 | $5 |
| Heart rhythm recording of continous external ekg over 8-15 days | 51 | $703 | $14 |
| Short return visit | 12 | $700 | $54 |
| Insertion of heart rhythm monitor under skin | 11 | $673 | $61 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 56 | $394 | $6 |
| Programming of dual lead pacemaker system | 11 | $374 | $34 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $193 | $16 |
| Ultrasonic guidance for blood vessel access | 11 | $131 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $50 | $3 |
2021: 43 services
| Short return visit (20+ min) | 700 | $97,338 | $81 |
| Return visit (30+ min) | 393 | $81,426 | $122 |
| Critical care, first 30-74 minutes | 140 | $65,367 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 243 | $55,323 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 237 | $50,527 | $205 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 462 | $29,380 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 147 | $28,240 | $174 |
| Long return visit (40+ min) | 110 | $25,159 | $181 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 67 | $15,102 | $225 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 97 | $10,956 | $24 |
| New patient visit (30+ min) | 100 | $10,286 | $103 |
| New patient visit (45+ min) | 60 | $9,508 | $158 |
| Initial hospital observation care per day, typically 70 minutes | 58 | $9,491 | $158 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 20 | $9,370 | $469 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 122 | $8,577 | $27 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 105 | $7,629 | $27 |
| Programming of dual lead pacemaker system | 74 | $7,609 | $77 |
| New patient visit (60+ min) | 33 | $7,183 | $218 |
| Telephone medical discussion with physician, 11-20 minutes | 75 | $5,872 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 318 | $5,678 | $13 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,602 | $467 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 550 | $5,521 | $7 |
| Telephone medical discussion with physician, 21-30 minutes | 44 | $5,436 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $4,432 | $65 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 29 | $3,208 | $23 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 17 | $3,140 | $185 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 220 | $2,880 | $13 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 97 | $2,250 | $23 |
| External shock to heart to regulate heart beat | 17 | $2,182 | $99 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $1,885 | $99 |
| Follow-up observation care per day, typically 35 minutes | 18 | $1,804 | $95 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 25 | $1,701 | $68 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 115 | $1,455 | $11 |
| Ultrasound of heart, follow-up | 55 | $1,392 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 19 | $1,312 | $33 |
| Heart rhythm recording of continous external ekg over 8-15 days | 88 | $1,310 | $15 |
| Programming of dual lead pacemaker system | 15 | $530 | $35 |
| Short return visit | 11 | $492 | $45 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 46 | $337 | $7 |
| Ultrasound of heart blood flow, valves and chambers | 18 | $316 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 30 | $189 | $6 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 25 | $125 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 32 | $95 | $3 |
2020: 42 services
| Critical care, first 30-74 minutes | 119 | $67,623 | $197 |
| Return visit (30+ min) | 358 | $55,514 | $97 |
| Short return visit (20+ min) | 531 | $55,196 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 215 | $54,562 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 169 | $36,491 | $204 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 164 | $32,680 | $180 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 389 | $26,390 | $63 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 77 | $18,009 | $222 |
| Telephone medical discussion with physician, 11-20 minutes | 170 | $15,333 | $70 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 32 | $14,742 | $461 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 97 | $13,990 | $24 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $13,763 | $510 |
| Initial hospital observation care per day, typically 70 minutes | 54 | $10,012 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 92 | $9,662 | $66 |
| Telephone medical discussion with physician, 21-30 minutes | 68 | $8,070 | $106 |
| Long return visit (40+ min) | 51 | $7,971 | $137 |
| Programming of dual lead pacemaker system | 74 | $7,671 | $68 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 112 | $6,538 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 95 | $5,618 | $27 |
| New patient visit (30+ min) | 52 | $4,671 | $90 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 25 | $4,565 | $25 |
| New patient visit (45+ min) | 27 | $4,376 | $162 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 416 | $4,215 | $7 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 48 | $4,162 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 193 | $3,670 | $16 |
| Follow-up observation care per day, typically 35 minutes | 25 | $2,801 | $97 |
| External shock to heart to regulate heart beat | 20 | $2,694 | $104 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 152 | $2,013 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 141 | $1,977 | $11 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 17 | $1,436 | $33 |
| Insertion of heart rhythm monitor under skin | 15 | $1,198 | $80 |
| Follow-up observation care per day, typically 25 minutes | 17 | $1,185 | $66 |
| Ultrasound of heart, follow-up | 31 | $914 | $24 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $912 | $70 |
| External ekg recording for more than 48 hours up to 21 days | 28 | $814 | $28 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $786 | $66 |
| Short return visit | 16 | $726 | $45 |
| Programming of dual lead pacemaker system | 18 | $613 | $34 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 24 | $595 | $25 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 21 | $178 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 23 | $147 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $45 | $3 |
2019: 41 services
| Return visit (30+ min) | 439 | $69,484 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 214 | $55,199 | $94 |
| Short return visit (20+ min) | 535 | $54,248 | $64 |
| Critical care, first 30-74 minutes | 93 | $43,843 | $195 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 192 | $39,897 | $204 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 183 | $34,554 | $174 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 488 | $32,349 | $63 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 80 | $17,713 | $213 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 116 | $13,345 | $65 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $13,341 | $476 |
| Long return visit (40+ min) | 85 | $12,968 | $128 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 67 | $12,353 | $24 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 25 | $11,632 | $465 |
| Follow-up observation care per day, typically 35 minutes | 71 | $9,580 | $94 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 75 | $7,003 | $91 |
| New patient visit (45+ min) | 49 | $6,798 | $139 |
| Programming of dual lead pacemaker system | 74 | $6,610 | $59 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 85 | $6,231 | $27 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 555 | $5,311 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 65 | $5,091 | $28 |
| New patient visit (30+ min) | 52 | $5,034 | $97 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 247 | $3,983 | $15 |
| New patient visit (60+ min) | 18 | $3,297 | $183 |
| Follow-up observation care per day, typically 25 minutes | 41 | $3,232 | $65 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 22 | $3,076 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 201 | $2,675 | $13 |
| External shock to heart to regulate heart beat | 22 | $2,355 | $98 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 19 | $1,906 | $41 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 154 | $1,904 | $11 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,765 | $88 |
| Long return visit (40+ min) | 19 | $1,748 | $87 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,596 | $100 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 24 | $1,592 | $66 |
| Programming of dual lead pacemaker system | 29 | $1,057 | $35 |
| Ultrasound of heart, follow-up | 33 | $870 | $23 |
| Return visit (30+ min) | 11 | $784 | $65 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $753 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 49 | $327 | $7 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $320 | $17 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 28 | $207 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $71 | $3 |
2018: 41 services
| Short return visit (20+ min) | 508 | $55,623 | $64 |
| Return visit (30+ min) | 345 | $53,027 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 199 | $33,650 | $167 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 157 | $31,257 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 158 | $30,727 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 338 | $22,248 | $64 |
| Critical care, first 30-74 minutes | 47 | $16,891 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 126 | $15,782 | $65 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $8,524 | $449 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 32 | $7,055 | $220 |
| New patient visit (30+ min) | 78 | $7,050 | $90 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 51 | $6,779 | $23 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 65 | $6,014 | $91 |
| New patient visit (45+ min) | 35 | $4,871 | $139 |
| Programming of dual lead pacemaker system | 58 | $4,607 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 249 | $4,014 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 415 | $3,999 | $7 |
| Long return visit (40+ min) | 33 | $3,977 | $121 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 57 | $3,135 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 48 | $2,701 | $26 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $2,347 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,177 | $121 |
| External shock to heart to regulate heart beat | 14 | $1,895 | $100 |
| Long return visit (40+ min) | 17 | $1,777 | $99 |
| New patient visit (60+ min) | 11 | $1,639 | $149 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 120 | $1,601 | $13 |
| Initial hospital observation care per day, typically 50 minutes | 11 | $1,329 | $121 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 64 | $1,272 | $20 |
| New patient visit (45+ min) | 11 | $1,255 | $114 |
| Follow-up observation care per day, typically 25 minutes | 16 | $1,110 | $65 |
| Return visit (30+ min) | 13 | $908 | $70 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 37 | $798 | $12 |
| Programming of dual lead pacemaker system | 22 | $795 | $35 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 52 | $630 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 27 | $536 | $20 |
| Ultrasonic guidance for blood vessel access | 40 | $534 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 64 | $511 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $360 | $13 |
| Ultrasound of heart, follow-up | 12 | $323 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 12 | $215 | $17 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $46 | $3 |
2017: 33 services
| Return visit (30+ min) | 367 | $68,066 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 185 | $46,746 | $91 |
| Short return visit (20+ min) | 441 | $41,783 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 156 | $32,402 | $177 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 213 | $15,950 | $74 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 191 | $10,945 | $56 |
| Critical care, first 30-74 minutes | 30 | $7,298 | $192 |
| New patient visit (45+ min) | 51 | $7,127 | $140 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 40 | $7,051 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 93 | $6,894 | $63 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 16 | $6,862 | $429 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 75 | $6,733 | $89 |
| New patient visit (30+ min) | 67 | $6,285 | $94 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $5,804 | $215 |
| New patient visit (60+ min) | 34 | $4,937 | $145 |
| Long return visit (40+ min) | 39 | $4,626 | $103 |
| Programming of dual lead pacemaker system | 64 | $4,564 | $49 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 21 | $4,290 | $204 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 369 | $3,636 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 51 | $3,575 | $27 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 41 | $3,202 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 181 | $3,100 | $15 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 15 | $2,477 | $22 |
| Programming of multiple lead implantable defibrillator system | 11 | $2,123 | $76 |
| External shock to heart to regulate heart beat | 16 | $2,063 | $98 |
| Follow-up observation care per day, typically 35 minutes | 18 | $1,845 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 190 | $1,638 | $7 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $906 | $76 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 26 | $841 | $12 |
| Programming of single lead pacemaker system | 12 | $778 | $43 |
| Ultrasonic guidance for blood vessel access | 32 | $413 | $13 |
| Programming of dual lead pacemaker system | 11 | $375 | $34 |
| Ultrasonic guidance for blood vessel access | 28 | $363 | $13 |
2016: 30 services
| Return visit (30+ min) | 329 | $52,568 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 199 | $42,154 | $89 |
| Short return visit (20+ min) | 404 | $39,780 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 189 | $36,304 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 123 | $13,206 | $62 |
| Critical care, first 30-74 minutes | 40 | $12,680 | $189 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 220 | $12,162 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 205 | $11,942 | $55 |
| New patient visit (45+ min) | 57 | $7,680 | $135 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $6,326 | $452 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 26 | $5,975 | $230 |
| New patient visit (30+ min) | 56 | $4,729 | $84 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 359 | $3,450 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,422 | $228 |
| Programming of dual lead pacemaker system | 45 | $3,025 | $42 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,004 | $116 |
| Long return visit (40+ min) | 19 | $2,125 | $106 |
| New patient visit (60+ min) | 12 | $1,882 | $157 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 134 | $1,860 | $12 |
| Programming of multiple lead implantable defibrillator system | 15 | $1,715 | $71 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 23 | $1,383 | $29 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 32 | $1,331 | $25 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $1,108 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 136 | $1,104 | $7 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 17 | $1,001 | $59 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 11 | $886 | $81 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 16 | $666 | $23 |
| Ultrasound of heart, follow-up | 21 | $470 | $22 |
| Ultrasonic guidance for blood vessel access | 30 | $371 | $12 |
| Ultrasonic guidance for blood vessel access | 18 | $240 | $13 |
2015: 27 services
| Short return visit (20+ min) | 426 | $47,865 | $60 |
| Return visit (30+ min) | 265 | $42,469 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 164 | $38,902 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 170 | $34,387 | $175 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 347 | $19,704 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 124 | $15,674 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 349 | $6,854 | $15 |
| Critical care, first 30-74 minutes | 22 | $6,460 | $190 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $5,962 | $426 |
| New patient visit (45+ min) | 43 | $5,912 | $137 |
| New patient visit (30+ min) | 62 | $5,860 | $95 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $5,207 | $217 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 516 | $4,989 | $7 |
| Programming of multiple lead implantable defibrillator system | 13 | $2,232 | $77 |
| Programming of dual lead pacemaker system | 32 | $1,994 | $46 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 35 | $1,937 | $55 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 24 | $1,737 | $72 |
| External shock to heart to regulate heart beat | 13 | $1,684 | $105 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 19 | $1,181 | $62 |
| Return visit (30+ min) | 13 | $877 | $67 |
| Hospital observation care on day of discharge | 12 | $761 | $63 |
| New patient visit (30+ min) | 11 | $721 | $66 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 19 | $718 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 14 | $531 | $29 |
| Ultrasound of heart, follow-up | 15 | $359 | $22 |
| Ultrasonic guidance for blood vessel access | 25 | $325 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 18 | $147 | $7 |
2014: 27 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 223 | $53,574 | $89 |
| Short return visit (20+ min) | 412 | $46,990 | $61 |
| Return visit (30+ min) | 284 | $40,147 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 154 | $31,807 | $174 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 402 | $23,064 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 83 | $9,160 | $62 |
| Critical care, first 30-74 minutes | 28 | $8,141 | $189 |
| New patient visit (30+ min) | 93 | $8,139 | $88 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 30 | $6,590 | $220 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 336 | $6,343 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 551 | $5,411 | $7 |
| Initial hospital observation care per day, typically 70 minutes | 23 | $3,973 | $159 |
| Long return visit (40+ min) | 23 | $3,364 | $120 |
| Follow-up observation care per day, typically 35 minutes | 28 | $2,880 | $90 |
| Programming of dual lead pacemaker system | 38 | $2,649 | $46 |
| New patient visit (45+ min) | 17 | $2,360 | $139 |
| Programming of multiple lead implantable defibrillator system | 12 | $2,000 | $71 |
| External shock to heart to regulate heart beat | 12 | $1,505 | $100 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 16 | $1,285 | $80 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 18 | $1,143 | $64 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $1,099 | $58 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $949 | $86 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 22 | $933 | $25 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 11 | $628 | $57 |
| Ultrasound of heart, follow-up | 23 | $579 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 11 | $541 | $28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 16 | $117 | $7 |
2013: 24 services
| Return visit (30+ min) | 251 | $39,166 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 192 | $37,357 | $170 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 186 | $35,616 | $87 |
| Short return visit (20+ min) | 324 | $32,500 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 399 | $22,461 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 137 | $15,966 | $60 |
| New patient visit (30+ min) | 183 | $15,060 | $82 |
| New patient visit (45+ min) | 64 | $8,653 | $135 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 562 | $4,864 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 272 | $4,731 | $16 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $4,203 | $210 |
| Programming of dual lead pacemaker system | 32 | $2,232 | $46 |
| Initial hospital observation care per day, typically 70 minutes | 12 | $2,001 | $154 |
| Long return visit (40+ min) | 16 | $1,951 | $122 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $1,655 | $72 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,515 | $84 |
| Programming of multiple lead implantable defibrillator system | 15 | $1,461 | $73 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 16 | $1,404 | $83 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 13 | $1,294 | $100 |
| Ultrasound of heart, follow-up | 16 | $408 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 21 | $392 | $19 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 14 | $361 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 21 | $260 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 23 | $161 | $7 |
Medicaid work
$28,089 in 2024
Medicaid paid $28,089 for 1,130 billed services this clinician did in 2024, up to 111 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 316 | $20,483 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 685 | $4,139 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 26 | $1,271 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 25 | $744 |
| Return visit (30+ min) | 12 | $602 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 35 | $352 |
| Short return visit (20+ min) | 13 | $349 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 18 | $148 |
| 2024 | 1,130 | 8 | 111 | $28,089 |
| 2023 | 1,109 | 3 | 173 | $13,557 |
| 2022 | 960 | 3 | 90 | $11,718 |
| 2021 | 737 | 3 | 66 | $9,867 |
| 2020 | 425 | 2 | 55 | $2,968 |
| 2019 | 546 | 2 | 75 | $6,074 |
| 2018 | 424 | 2 | 53 | $3,521 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 296 | $8,197 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 759 | $4,171 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 54 | $1,189 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 195 | $6,379 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 682 | $3,334 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 83 | $2,006 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 166 | $5,411 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 111 | $2,634 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 460 | $1,821 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 369 | $1,572 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 56 | $1,397 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 102 | $4,085 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 444 | $1,990 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 37 | $1,818 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 387 | $1,703 |
Drugs they prescribed that Part D paid
$1,878,401
Pharmacies billed $1,878,401 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
6,974 generic and fewer than 11 brand-name prescriptions · $1,878,401 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 584 | $669,874 | $1,147 |
| Xarelto | 380 | $488,605 | $1,286 |
| Farxiga | 180 | $178,774 | $993 |
| Entresto | 134 | $157,118 | $1,173 |
| Brilinta | 74 | $61,496 | $831 |
See all 62 drugs
| Eliquis | 584 | $669,874 | $1,147 |
| Xarelto | 380 | $488,605 | $1,286 |
| Farxiga | 180 | $178,774 | $993 |
| Entresto | 134 | $157,118 | $1,173 |
| Brilinta | 74 | $61,496 | $831 |
| Multaq | 37 | $59,142 | $1,598 |
| Jardiance | 56 | $58,176 | $1,039 |
| Repatha Sureclick | 28 | $38,587 | $1,378 |
| Praluent | 15 | $16,275 | $1,085 |
| Flecainide Acetate | 243 | $11,977 | $49 |
| Atorvastatin | 901 | $10,246 | $11 |
| Rosuvastatin | 539 | $8,846 | $16 |
| Metoprolol | 614 | $8,438 | $14 |
| Ranolazine Er | 49 | $7,357 | $150 |
| Losartan | 447 | $5,615 | $13 |
| Carvedilol | 395 | $3,825 | $10 |
| Diltiazem 24hr Er (Cd) | 94 | $3,799 | $40 |
| Clopidogrel | 320 | $3,214 | $10 |
| Amlodipine Besylate | 416 | $3,209 | $8 |
| Prasugrel | 20 | $2,450 | $122 |
| Lisinopril | 308 | $2,443 | $8 |
| Potassium Chloride | 113 | $2,337 | $21 |
| Metoprolol | 252 | $2,179 | $9 |
| Hydralazine | 138 | $2,151 | $16 |
| Furosemide | 287 | $1,952 | $7 |
| Amiodarone | 62 | $1,948 | $31 |
| Propafenone | 30 | $1,775 | $59 |
| Valsartan | 67 | $1,761 | $26 |
| Digoxin | 89 | $1,683 | $19 |
| Olmesartan Medoxomil | 51 | $1,551 | $30 |
| Nitroglycerin | 131 | $1,415 | $11 |
| Atenolol | 129 | $1,367 | $11 |
| Spironolactone | 133 | $1,149 | $9 |
| Simvastatin | 96 | $1,094 | $11 |
| Bumetanide | 31 | $1,087 | $35 |
| Labetalol | 28 | $1,013 | $36 |
| Isosorbide Mononitrate Er | 89 | $993 | $11 |
| Diltiazem 24hr Er | 26 | $953 | $37 |
| Losartan-Hydrochlorothiazide | 23 | $895 | $39 |
| Hydrochlorothiazide | 126 | $891 | $7 |
| Pantoprazole | 51 | $856 | $17 |
| Clonidine | 82 | $768 | $9 |
| Warfarin | 43 | $618 | $14 |
| Nebivolol | 12 | $587 | $49 |
| Irbesartan | 32 | $542 | $17 |
| Ezetimibe | 35 | $534 | $15 |
| Enalapril Maleate | 15 | $383 | $26 |
| Telmisartan | 16 | $339 | $21 |
| Bisoprolol | 25 | $327 | $13 |
| Propranolol | 12 | $297 | $25 |
| Diltiazem | 22 | $297 | $14 |
| Klor-Con 10 | 14 | $290 | $21 |
| Pravastatin | 30 | $289 | $10 |
| Fludrocortisone Acetate | 18 | $281 | $16 |
| Tamsulosin | 14 | $276 | $20 |
| Triamterene-Hydrochlorothiazid | 16 | $211 | $13 |
| Gabapentin | 18 | $188 | $10 |
| Benazepril | 31 | $183 | $6 |
| Levothyroxine | 14 | $177 | $13 |
| Metformin | 18 | $176 | $10 |
| Metolazone | 11 | $135 | $12 |
| Lovastatin | 11 | $127 | $12 |
Year by year
| 2024 | 8,612 | 1,087 | None | None | $1,878,401 |
| 2023 | 7,607 | 946 | None | 19% | $1,746,577 |
| 2022 | 6,449 | 771 | 0% (0) | None | $1,309,358 |
| 2021 | 5,696 | 697 | 0% (0) | 17% | $1,026,078 |
| 2020 | 5,165 | 605 | None | 18% | $837,135 |
| 2019 | 4,649 | 583 | 0% (12) | 20% | $757,229 |
| 2018 | 4,796 | 507 | None | 24% | $685,210 |
| 2017 | 4,416 | 449 | None | 27% | $518,396 |
| 2016 | 4,158 | 393 | 0% (15) | None | $416,288 |
| 2015 | 3,709 | 352 | 1% (19) | None | $327,278 |
| 2014 | 3,484 | 310 | 1% (22) | None | $252,692 |
| 2013 | 2,496 | 246 | 1% (17) | None | $129,253 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 67 drugs
| Eliquis | 496 | $577,804 | $1,165 |
| Xarelto | 356 | $463,834 | $1,303 |
| Farxiga | 144 | $151,649 | $1,053 |
| Entresto | 98 | $122,288 | $1,248 |
| Brilinta | 98 | $74,928 | $765 |
| Multaq | 47 | $72,588 | $1,544 |
| Jardiance | 43 | $41,672 | $969 |
| Repatha Sureclick | 13 | $15,288 | $1,176 |
| Flecainide Acetate | 233 | $15,213 | $65 |
| Praluent | 12 | $12,548 | $1,046 |
| Atorvastatin | 723 | $11,086 | $15 |
| Metoprolol | 483 | $10,198 | $21 |
| Ranolazine Er | 32 | $7,347 | $230 |
| Rosuvastatin | 390 | $7,151 | $18 |
| Losartan | 425 | $6,805 | $16 |
| Diltiazem 24hr Er (Cd) | 134 | $6,147 | $46 |
| Prasugrel | 34 | $5,724 | $168 |
| Clopidogrel | 262 | $4,645 | $18 |
| Carvedilol | 330 | $4,519 | $14 |
| Potassium Chloride | 110 | $3,771 | $34 |
| Propafenone | 43 | $3,691 | $86 |
| Hydralazine | 131 | $3,429 | $26 |
| Amlodipine Besylate | 350 | $3,123 | $9 |
| Amiodarone | 83 | $3,119 | $38 |
| Valsartan | 56 | $2,896 | $52 |
| Furosemide | 327 | $2,489 | $8 |
| Lisinopril | 232 | $2,406 | $10 |
| Metoprolol | 222 | $2,342 | $11 |
| Digoxin | 82 | $2,291 | $28 |
| Verapamil Sr | 20 | $2,113 | $106 |
| Simvastatin | 133 | $1,964 | $15 |
| Isosorbide Mononitrate Er | 77 | $1,734 | $23 |
| Ezetimibe | 31 | $1,695 | $55 |
| Labetalol | 28 | $1,632 | $58 |
| Atenolol | 119 | $1,570 | $13 |
| Bumetanide | 25 | $1,493 | $60 |
| Olmesartan Medoxomil | 40 | $1,396 | $35 |
| Midodrine | 21 | $1,336 | $64 |
| Nitroglycerin | 89 | $1,310 | $15 |
| Clonidine | 82 | $1,291 | $16 |
| Spironolactone | 79 | $1,054 | $13 |
| Cartia Xt | 18 | $1,048 | $58 |
| Losartan-Hydrochlorothiazide | 21 | $986 | $47 |
| Diltiazem 24hr Er | 16 | $900 | $56 |
| Sotalol | 17 | $798 | $47 |
| Warfarin | 58 | $735 | $13 |
| Bisoprolol | 22 | $720 | $33 |
| Pantoprazole | 40 | $700 | $18 |
| Doxazosin Mesylate | 15 | $526 | $35 |
| Metolazone | 14 | $475 | $34 |
| Hydrochlorothiazide | 120 | $462 | $4 |
| Propranolol | 15 | $400 | $27 |
| Enalapril Maleate | 14 | $387 | $28 |
| Diltiazem | 20 | $385 | $19 |
| Benazepril | 24 | $351 | $15 |
| Irbesartan | 20 | $344 | $17 |
| Levothyroxine | 18 | $280 | $16 |
| Pravastatin | 30 | $271 | $9 |
| Chlorthalidone | 15 | $255 | $17 |
| Tamsulosin | 22 | $251 | $11 |
| Lovastatin | 11 | $240 | $22 |
| Metformin | 17 | $202 | $12 |
| Fludrocortisone Acetate | 12 | $165 | $14 |
| Lorazepam | 15 | $108 | $7 |
| Gabapentin | 14 | $103 | $7 |
| Triamterene-Hydrochlorothiazid | 11 | $75 | $7 |
| Ramipril | 12 | $31 | $3 |
2022: 62 drugs
| Eliquis | 325 | $382,539 | $1,177 |
| Xarelto | 320 | $369,402 | $1,154 |
| Entresto | 81 | $93,595 | $1,155 |
| Farxiga | 76 | $82,146 | $1,081 |
| Brilinta | 63 | $55,999 | $889 |
| Jardiance | 39 | $39,102 | $1,003 |
| Multaq | 21 | $32,062 | $1,527 |
| Repatha Sureclick | 22 | $22,184 | $1,008 |
| Repatha | 11 | $15,163 | $1,378 |
| Flecainide Acetate | 195 | $14,227 | $73 |
| Praluent | 19 | $10,190 | $536 |
| Atorvastatin | 571 | $8,925 | $16 |
| Rosuvastatin | 265 | $7,703 | $29 |
| Metoprolol | 392 | $7,528 | $19 |
| Propafenone Hcl Er | 15 | $7,075 | $472 |
| Ranolazine Er | 31 | $6,240 | $201 |
| Prasugrel | 28 | $5,513 | $197 |
| Losartan | 342 | $4,538 | $13 |
| Carvedilol | 314 | $4,409 | $14 |
| Verapamil Sr | 14 | $4,296 | $307 |
| Diltiazem 24hr Er (Cd) | 105 | $4,075 | $39 |
| Valsartan | 63 | $4,064 | $65 |
| Hydralazine | 113 | $4,046 | $36 |
| Amiodarone | 96 | $3,967 | $41 |
| Clopidogrel | 227 | $3,809 | $17 |
| Amlodipine Besylate | 321 | $3,190 | $10 |
| Potassium Chloride | 128 | $3,108 | $24 |
| Propafenone | 39 | $2,887 | $74 |
| Bumetanide | 32 | $2,540 | $79 |
| Digoxin | 65 | $2,280 | $35 |
| Ezetimibe | 27 | $1,874 | $69 |
| Furosemide | 306 | $1,836 | $6 |
| Isosorbide Mononitrate Er | 74 | $1,795 | $24 |
| Lisinopril | 222 | $1,789 | $8 |
| Labetalol | 20 | $1,615 | $81 |
| Metoprolol | 181 | $1,612 | $9 |
| Simvastatin | 119 | $1,455 | $12 |
| Nitroglycerin | 70 | $1,147 | $16 |
| Losartan-Hydrochlorothiazide | 18 | $1,119 | $62 |
| Atenolol | 128 | $1,093 | $9 |
| Clonidine | 86 | $992 | $12 |
| Diltiazem 24hr Er | 12 | $756 | $63 |
| Olmesartan Medoxomil | 28 | $748 | $27 |
| Warfarin | 67 | $746 | $11 |
| Dilt-Xr | 15 | $704 | $47 |
| Spironolactone | 66 | $700 | $11 |
| Pantoprazole | 33 | $634 | $19 |
| Sotalol | 23 | $586 | $25 |
| Benazepril | 22 | $565 | $26 |
| Pravastatin | 32 | $544 | $17 |
| Levothyroxine | 23 | $505 | $22 |
| Hydrochlorothiazide | 89 | $464 | $5 |
| Propranolol | 12 | $414 | $34 |
| Diltiazem | 14 | $409 | $29 |
| Doxazosin Mesylate | 23 | $378 | $16 |
| Irbesartan | 12 | $264 | $22 |
| Triamterene-Hydrochlorothiazid | 16 | $208 | $13 |
| Metformin | 15 | $204 | $14 |
| Ramipril | 12 | $141 | $12 |
| Gabapentin | 18 | $134 | $7 |
| Tamsulosin | 11 | $71 | $6 |
| Lorazepam | 15 | $52 | $3 |
2021: 59 drugs
| Xarelto | 279 | $337,983 | $1,211 |
| Eliquis | 315 | $328,694 | $1,043 |
| Entresto | 74 | $74,495 | $1,007 |
| Brilinta | 59 | $45,394 | $769 |
| Flecainide Acetate | 206 | $19,240 | $93 |
| Repatha Sureclick | 15 | $18,555 | $1,237 |
| Multaq | 13 | $13,840 | $1,065 |
| Livalo | 16 | $10,912 | $682 |
| Rosuvastatin | 197 | $10,108 | $51 |
| Atorvastatin | 496 | $8,910 | $18 |
| Metoprolol | 336 | $7,345 | $22 |
| Praluent | 15 | $6,927 | $462 |
| Ranolazine Er | 23 | $6,724 | $292 |
| Valsartan | 75 | $5,481 | $73 |
| Prasugrel | 35 | $4,759 | $136 |
| Losartan | 266 | $4,043 | $15 |
| Niacin Er | 15 | $3,933 | $262 |
| Bumetanide | 33 | $3,663 | $111 |
| Potassium Chloride | 113 | $3,567 | $32 |
| Carvedilol | 251 | $3,276 | $13 |
| Diltiazem 24hr Er (Cd) | 61 | $3,259 | $53 |
| Clopidogrel | 204 | $3,130 | $15 |
| Propafenone | 37 | $2,780 | $75 |
| Hydralazine | 97 | $2,756 | $28 |
| Amlodipine Besylate | 295 | $2,552 | $9 |
| Amiodarone | 104 | $2,434 | $23 |
| Olmesartan Medoxomil | 29 | $2,401 | $83 |
| Digoxin | 56 | $2,102 | $38 |
| Isosorbide Mononitrate Er | 74 | $1,772 | $24 |
| Furosemide | 241 | $1,755 | $7 |
| Labetalol | 22 | $1,703 | $77 |
| Lisinopril | 212 | $1,684 | $8 |
| Metoprolol | 156 | $1,669 | $11 |
| Ezetimibe | 21 | $1,637 | $78 |
| Simvastatin | 129 | $1,553 | $12 |
| Nitroglycerin | 93 | $1,481 | $16 |
| Losartan-Hydrochlorothiazide | 19 | $1,266 | $67 |
| Atenolol | 122 | $1,020 | $8 |
| Warfarin | 79 | $1,001 | $13 |
| Mometasone Furoate | 12 | $986 | $82 |
| Dilt-Xr | 19 | $979 | $52 |
| Clonidine | 89 | $931 | $10 |
| Benazepril | 21 | $724 | $34 |
| Diltiazem | 15 | $715 | $48 |
| Propranolol | 22 | $708 | $32 |
| Pacerone | 13 | $702 | $54 |
| Pantoprazole | 36 | $674 | $19 |
| Midodrine | 12 | $669 | $56 |
| Diltiazem 24hr Er | 16 | $665 | $42 |
| Pravastatin | 26 | $560 | $22 |
| Doxazosin Mesylate | 16 | $536 | $34 |
| Hydrochlorothiazide | 83 | $516 | $6 |
| Spironolactone | 32 | $503 | $16 |
| Enalapril Maleate | 14 | $497 | $36 |
| Lovastatin | 11 | $206 | $19 |
| Ramipril | 17 | $176 | $10 |
| Triamterene-Hydrochlorothiazid | 11 | $156 | $14 |
| Klor-Con 10 | 11 | $107 | $10 |
| Lorazepam | 13 | $50 | $4 |
2020: 54 drugs
| Xarelto | 286 | $311,737 | $1,090 |
| Eliquis | 247 | $238,848 | $967 |
| Brilinta | 76 | $51,548 | $678 |
| Entresto | 33 | $33,906 | $1,027 |
| Flecainide Acetate | 205 | $21,943 | $107 |
| Repatha Sureclick | 23 | $15,881 | $690 |
| Propafenone Hcl Er | 12 | $13,925 | $1,160 |
| Atorvastatin | 463 | $9,401 | $20 |
| Ranolazine Er | 35 | $7,615 | $218 |
| Livalo | 13 | $7,379 | $568 |
| Metoprolol | 323 | $7,298 | $23 |
| Rosuvastatin | 117 | $6,277 | $54 |
| Valsartan | 66 | $4,572 | $69 |
| Amiodarone | 117 | $4,387 | $37 |
| Losartan | 272 | $4,149 | $15 |
| Potassium Chloride | 95 | $3,152 | $33 |
| Prasugrel | 31 | $3,114 | $100 |
| Diltiazem 24hr Er (Cd) | 59 | $2,921 | $50 |
| Bumetanide | 31 | $2,878 | $93 |
| Clopidogrel | 164 | $2,847 | $17 |
| Olmesartan Medoxomil | 42 | $2,498 | $59 |
| Amlodipine Besylate | 267 | $2,478 | $9 |
| Hydralazine | 103 | $2,287 | $22 |
| Telmisartan-Hydrochlorothiazid | 12 | $2,276 | $190 |
| Carvedilol | 176 | $2,262 | $13 |
| Isosorbide Mononitrate Er | 99 | $2,223 | $22 |
| Warfarin | 112 | $2,142 | $19 |
| Propafenone | 30 | $2,072 | $69 |
| Lisinopril | 197 | $1,752 | $9 |
| Furosemide | 219 | $1,672 | $8 |
| Digoxin | 37 | $1,431 | $39 |
| Simvastatin | 110 | $1,414 | $13 |
| Losartan-Hydrochlorothiazide | 15 | $1,354 | $90 |
| Metoprolol | 161 | $1,249 | $8 |
| Atenolol | 141 | $1,224 | $9 |
| Telmisartan | 14 | $1,059 | $76 |
| Cartia Xt | 20 | $1,026 | $51 |
| Clonidine | 87 | $932 | $11 |
| Mometasone Furoate | 12 | $878 | $73 |
| Irbesartan | 12 | $867 | $72 |
| Nitroglycerin | 54 | $845 | $16 |
| Metolazone | 14 | $830 | $59 |
| Dilt-Xr | 13 | $830 | $64 |
| Propranolol | 22 | $802 | $36 |
| Pravastatin | 26 | $766 | $29 |
| Pantoprazole | 36 | $577 | $16 |
| Benazepril | 12 | $475 | $40 |
| Hydrochlorothiazide | 67 | $427 | $6 |
| Doxazosin Mesylate | 11 | $298 | $27 |
| Diltiazem 24hr Er | 14 | $260 | $19 |
| Spironolactone | 23 | $243 | $11 |
| Gabapentin | 15 | $211 | $14 |
| Lovastatin | 12 | $209 | $17 |
| Lorazepam | 18 | $99 | $5 |
2019: 50 drugs
| Xarelto | 278 | $294,568 | $1,060 |
| Eliquis | 201 | $198,919 | $990 |
| Brilinta | 113 | $70,451 | $623 |
| Flecainide Acetate | 182 | $16,463 | $90 |
| Repatha Sureclick | 23 | $12,128 | $527 |
| Propafenone Hcl Er | 11 | $10,583 | $962 |
| Ranolazine Er | 36 | $9,869 | $274 |
| Ranexa | 13 | $8,302 | $639 |
| Metoprolol | 243 | $7,412 | $31 |
| Atorvastatin | 409 | $6,955 | $17 |
| Rosuvastatin | 110 | $6,382 | $58 |
| Prasugrel | 33 | $5,887 | $178 |
| Livalo | 14 | $5,632 | $402 |
| Potassium Chloride | 98 | $5,246 | $54 |
| Amiodarone | 100 | $4,135 | $41 |
| Valsartan | 57 | $3,136 | $55 |
| Diltiazem 24hr Er (Cd) | 51 | $2,848 | $56 |
| Carvedilol | 203 | $2,774 | $14 |
| Bumetanide | 33 | $2,744 | $83 |
| Olmesartan Medoxomil | 35 | $2,722 | $78 |
| Isosorbide Mononitrate Er | 94 | $2,556 | $27 |
| Warfarin | 140 | $2,433 | $17 |
| Lisinopril | 226 | $2,405 | $11 |
| Clopidogrel | 132 | $2,341 | $18 |
| Losartan | 188 | $2,196 | $12 |
| Propafenone | 31 | $2,065 | $67 |
| Digoxin | 39 | $2,023 | $52 |
| Amlodipine Besylate | 219 | $1,953 | $9 |
| Furosemide | 219 | $1,751 | $8 |
| Telmisartan-Hydrochlorothiazid | 11 | $1,676 | $152 |
| Hydralazine | 70 | $1,494 | $21 |
| Cartia Xt | 26 | $1,334 | $51 |
| Atenolol | 106 | $1,113 | $11 |
| Dilt-Xr | 25 | $984 | $39 |
| Nitroglycerin | 60 | $984 | $16 |
| Simvastatin | 81 | $983 | $12 |
| Propranolol | 32 | $913 | $29 |
| Metoprolol | 121 | $820 | $7 |
| Cilostazol | 14 | $606 | $43 |
| Pantoprazole | 36 | $597 | $17 |
| Clonidine | 58 | $545 | $9 |
| Pravastatin | 21 | $450 | $21 |
| Levothyroxine | 11 | $385 | $35 |
| Losartan-Hydrochlorothiazide | 13 | $309 | $24 |
| Spironolactone | 30 | $306 | $10 |
| Hydrochlorothiazide | 51 | $293 | $6 |
| Sotalol | 14 | $268 | $19 |
| Ramipril | 13 | $254 | $20 |
| Lorazepam | 35 | $222 | $6 |
| Hydrocodone-Acetaminophen | 11 | $122 | $11 |
2018: 55 drugs
| Xarelto | 347 | $244,828 | $706 |
| Eliquis | 220 | $157,371 | $715 |
| Brilinta | 87 | $50,288 | $578 |
| Ranexa | 57 | $31,273 | $549 |
| Repatha Sureclick | 25 | $29,752 | $1,190 |
| Entresto | 20 | $17,111 | $856 |
| Prasugrel | 29 | $12,599 | $434 |
| Flecainide Acetate | 181 | $10,807 | $60 |
| Potassium Chloride | 123 | $8,819 | $72 |
| Propafenone Hcl Er | 15 | $8,753 | $584 |
| Metoprolol | 219 | $7,014 | $32 |
| Rosuvastatin | 83 | $6,057 | $73 |
| Atorvastatin | 369 | $5,998 | $16 |
| Livalo | 12 | $5,367 | $447 |
| Olmesartan Medoxomil | 46 | $4,549 | $99 |
| Niacin Er | 12 | $3,053 | $254 |
| Clopidogrel | 161 | $3,032 | $19 |
| Digoxin | 57 | $2,861 | $50 |
| Amiodarone | 92 | $2,634 | $29 |
| Carvedilol | 252 | $2,422 | $10 |
| Isosorbide Mononitrate Er | 105 | $2,412 | $23 |
| Valsartan | 45 | $2,131 | $47 |
| Warfarin | 149 | $1,967 | $13 |
| Propafenone | 27 | $1,938 | $72 |
| Diltiazem 24hr Er (Cd) | 49 | $1,796 | $37 |
| Bumetanide | 40 | $1,784 | $45 |
| Lisinopril | 217 | $1,780 | $8 |
| Amlodipine Besylate | 175 | $1,423 | $8 |
| Furosemide | 268 | $1,377 | $5 |
| Losartan | 118 | $1,258 | $11 |
| Nitroglycerin | 52 | $1,192 | $23 |
| Metoprolol | 119 | $1,110 | $9 |
| Cartia Xt | 31 | $1,039 | $34 |
| Simvastatin | 94 | $948 | $10 |
| Hydralazine | 73 | $810 | $11 |
| Atenolol | 91 | $772 | $8 |
| Metolazone | 14 | $631 | $45 |
| Propranolol | 21 | $589 | $28 |
| Dilt-Xr | 18 | $553 | $31 |
| Levothyroxine | 21 | $500 | $24 |
| Diltiazem 24hr Er | 19 | $494 | $26 |
| Cilostazol | 14 | $481 | $34 |
| Pantoprazole | 39 | $427 | $11 |
| Pravastatin | 28 | $400 | $14 |
| Enalapril Maleate | 14 | $377 | $27 |
| Irbesartan | 15 | $353 | $24 |
| Hydrochlorothiazide | 46 | $275 | $6 |
| Allopurinol | 12 | $248 | $21 |
| Sotalol | 20 | $242 | $12 |
| Lorazepam | 44 | $222 | $5 |
| Spironolactone | 17 | $218 | $13 |
| Clonidine | 49 | $207 | $4 |
| Losartan-Hydrochlorothiazide | 11 | $181 | $16 |
| Klor-Con 10 | 12 | $174 | $15 |
| Gabapentin | 11 | $89 | $8 |
2017: 56 drugs
| Xarelto | 304 | $174,019 | $572 |
| Eliquis | 185 | $106,527 | $576 |
| Effient | 43 | $26,768 | $623 |
| Brilinta | 50 | $21,819 | $436 |
| Repatha Sureclick | 12 | $14,720 | $1,227 |
| Entresto | 20 | $13,295 | $665 |
| Ranexa | 29 | $11,560 | $399 |
| Flecainide Acetate | 141 | $9,729 | $69 |
| Pradaxa | 15 | $9,347 | $623 |
| Potassium Chloride | 102 | $5,646 | $55 |
| Atorvastatin | 341 | $5,435 | $16 |
| Niacin Er | 22 | $5,052 | $230 |
| Metoprolol | 166 | $4,807 | $29 |
| Rosuvastatin | 54 | $4,377 | $81 |
| Olmesartan Medoxomil | 21 | $3,514 | $167 |
| Digoxin | 64 | $3,413 | $53 |
| Valsartan | 59 | $2,644 | $45 |
| Clopidogrel | 152 | $2,501 | $16 |
| Bumetanide | 39 | $2,478 | $64 |
| Amiodarone | 115 | $2,394 | $21 |
| Warfarin | 139 | $2,151 | $15 |
| Carvedilol | 233 | $1,956 | $8 |
| Isosorbide Mononitrate Er | 92 | $1,823 | $20 |
| Diltiazem 24hr Er | 81 | $1,774 | $22 |
| Amlodipine Besylate | 157 | $1,371 | $9 |
| Lisinopril | 167 | $1,366 | $8 |
| Losartan | 105 | $1,177 | $11 |
| Furosemide | 232 | $1,129 | $5 |
| Metoprolol | 164 | $1,099 | $7 |
| Fenofibrate | 11 | $1,073 | $98 |
| Synthroid | 11 | $1,039 | $94 |
| Digox | 21 | $1,032 | $49 |
| Simvastatin | 102 | $929 | $9 |
| Labetalol | 23 | $800 | $35 |
| Fenofibrate | 11 | $756 | $69 |
| Pravastatin | 34 | $734 | $22 |
| Nitroglycerin | 33 | $721 | $22 |
| Levothyroxine | 31 | $610 | $20 |
| Cartia Xt | 23 | $606 | $26 |
| Propafenone | 20 | $594 | $30 |
| Propranolol Hcl Er | 12 | $497 | $41 |
| Pantoprazole | 43 | $496 | $12 |
| Lorazepam | 62 | $485 | $8 |
| Dilt-Xr | 13 | $473 | $36 |
| Sotalol | 24 | $426 | $18 |
| Atenolol | 76 | $417 | $5 |
| Ramipril | 14 | $343 | $25 |
| Allopurinol | 22 | $321 | $15 |
| Hydralazine | 26 | $312 | $12 |
| Lansoprazole | 11 | $259 | $24 |
| Clonidine | 53 | $248 | $5 |
| Hydrochlorothiazide | 31 | $231 | $7 |
| Spironolactone | 16 | $221 | $14 |
| Lovastatin | 16 | $126 | $8 |
| Verapamil Er | 12 | $124 | $10 |
| Triamterene-Hydrochlorothiazid | 13 | $109 | $8 |
2016: 62 drugs
| Xarelto | 273 | $130,134 | $477 |
| Eliquis | 141 | $69,832 | $495 |
| Effient | 46 | $20,720 | $450 |
| Crestor | 35 | $19,615 | $560 |
| Brilinta | 48 | $18,631 | $388 |
| Praluent | 11 | $14,648 | $1,332 |
| Pradaxa | 22 | $9,120 | $415 |
| Benicar | 17 | $8,797 | $517 |
| Niacin Er | 19 | $5,174 | $272 |
| Atorvastatin | 306 | $5,092 | $17 |
| Rosuvastatin | 22 | $4,346 | $198 |
| Lipitor | 13 | $4,207 | $324 |
| Ranexa | 12 | $3,893 | $324 |
| Potassium Chloride | 94 | $3,829 | $41 |
| Flecainide Acetate | 124 | $3,697 | $30 |
| Valsartan | 55 | $3,508 | $64 |
| Diltiazem 24hr Er | 89 | $3,049 | $34 |
| Metoprolol | 98 | $2,678 | $27 |
| Digoxin | 56 | $2,395 | $43 |
| Clopidogrel | 124 | $2,339 | $19 |
| Carvedilol | 218 | $2,162 | $10 |
| Bumetanide | 44 | $2,020 | $46 |
| Amiodarone | 124 | $2,015 | $16 |
| Meprobamate | 11 | $1,951 | $177 |
| Warfarin | 152 | $1,866 | $12 |
| Isosorbide Mononitrate Er | 82 | $1,616 | $20 |
| Metoprolol | 177 | $1,185 | $7 |
| Furosemide | 239 | $1,172 | $5 |
| Digox | 30 | $1,131 | $38 |
| Labetalol | 34 | $1,118 | $33 |
| Amlodipine Besylate | 156 | $1,111 | $7 |
| Simvastatin | 102 | $1,020 | $10 |
| Synthroid | 12 | $974 | $81 |
| Pravastatin | 33 | $960 | $29 |
| Losartan | 79 | $943 | $12 |
| Lisinopril | 158 | $942 | $6 |
| Propranolol | 22 | $893 | $41 |
| Cartia Xt | 15 | $842 | $56 |
| Levothyroxine | 34 | $718 | $21 |
| Lorazepam | 72 | $716 | $10 |
| Nitrostat | 24 | $705 | $29 |
| Diltiazem 24hr Cd | 15 | $665 | $44 |
| Pantoprazole | 53 | $534 | $10 |
| Sotalol | 21 | $528 | $25 |
| Diltiazem Er | 20 | $516 | $26 |
| Hydralazine | 38 | $508 | $13 |
| Hydrocodone-Acetaminophen | 13 | $480 | $37 |
| Fenofibrate | 12 | $410 | $34 |
| Lansoprazole | 12 | $347 | $29 |
| Dilt-Xr | 11 | $320 | $29 |
| Atenolol | 38 | $276 | $7 |
| Propranolol Hcl Er | 12 | $262 | $22 |
| Propafenone | 18 | $232 | $13 |
| Escitalopram | 13 | $229 | $18 |
| Fluticasone Propionate | 13 | $224 | $17 |
| Clonidine | 29 | $197 | $7 |
| Hydrochlorothiazide | 29 | $148 | $5 |
| Metformin | 15 | $148 | $10 |
| Allopurinol | 14 | $132 | $9 |
| Lovastatin | 16 | $103 | $6 |
| Oxybutynin Chloride | 11 | $92 | $8 |
| Alprazolam | 11 | $49 | $4 |
2015: 59 drugs
| Xarelto | 254 | $100,829 | $397 |
| Eliquis | 98 | $39,787 | $406 |
| Crestor | 64 | $26,820 | $419 |
| Effient | 38 | $13,346 | $351 |
| Pradaxa | 27 | $12,433 | $460 |
| Brilinta | 28 | $10,328 | $369 |
| Benicar | 16 | $6,940 | $434 |
| Diovan | 21 | $6,828 | $325 |
| Amiodarone | 138 | $6,636 | $48 |
| Diltiazem 24hr Er | 56 | $5,146 | $92 |
| Niacin Er | 12 | $4,547 | $379 |
| Atorvastatin | 285 | $4,354 | $15 |
| Digoxin | 71 | $3,439 | $48 |
| Valsartan | 28 | $3,236 | $116 |
| Flecainide Acetate | 91 | $3,033 | $33 |
| Potassium Chloride | 73 | $3,005 | $41 |
| Vytorin | 13 | $2,723 | $209 |
| Metoprolol | 82 | $2,528 | $31 |
| Warfarin | 193 | $2,518 | $13 |
| Digox | 53 | $2,183 | $41 |
| Bumetanide | 37 | $1,888 | $51 |
| Diltiazem 24hr Cd | 25 | $1,855 | $74 |
| Carvedilol | 246 | $1,731 | $7 |
| Lanoxin | 12 | $1,579 | $132 |
| Meprobamate | 11 | $1,567 | $142 |
| Clopidogrel | 75 | $1,498 | $20 |
| Metolazone | 15 | $947 | $63 |
| Labetalol | 29 | $942 | $32 |
| Pravastatin | 19 | $902 | $47 |
| Diltiazem Er | 36 | $890 | $25 |
| Hydrocodone-Acetaminophen | 15 | $888 | $59 |
| Amlodipine Besylate | 137 | $830 | $6 |
| Lisinopril | 151 | $815 | $5 |
| Losartan | 91 | $806 | $9 |
| Furosemide | 181 | $777 | $4 |
| Levothyroxine | 34 | $766 | $23 |
| Cartia Xt | 19 | $692 | $36 |
| Simvastatin | 99 | $651 | $7 |
| Propranolol Hcl Er | 12 | $627 | $52 |
| Metoprolol | 110 | $618 | $6 |
| Isosorbide Mononitrate Er | 30 | $499 | $17 |
| Nitrostat | 26 | $472 | $18 |
| Pantoprazole | 38 | $456 | $12 |
| Tamsulosin | 13 | $441 | $34 |
| Propranolol | 19 | $399 | $21 |
| Hydralazine | 30 | $358 | $12 |
| Lorazepam | 56 | $316 | $6 |
| Lansoprazole | 12 | $312 | $26 |
| Fluticasone Propionate | 15 | $259 | $17 |
| Losartan-Hydrochlorothiazide | 12 | $224 | $19 |
| Atenolol | 30 | $203 | $7 |
| Escitalopram | 16 | $203 | $13 |
| Hydrochlorothiazide | 24 | $179 | $7 |
| Verapamil Er | 11 | $155 | $14 |
| Metformin | 22 | $150 | $7 |
| Sotalol | 11 | $123 | $11 |
| Clonidine | 22 | $84 | $4 |
| Klor-Con 8 | 11 | $79 | $7 |
| Lovastatin | 13 | $65 | $5 |
2014: 64 drugs
| Xarelto | 163 | $58,259 | $357 |
| Crestor | 82 | $23,694 | $289 |
| Eliquis | 65 | $22,306 | $343 |
| Diovan | 40 | $10,302 | $258 |
| Pradaxa | 17 | $7,372 | $434 |
| Amiodarone | 127 | $5,300 | $42 |
| Atorvastatin | 266 | $5,293 | $20 |
| Effient | 17 | $5,173 | $304 |
| Diltiazem 24hr Er | 77 | $5,162 | $67 |
| Lipitor | 12 | $4,701 | $392 |
| Diltiazem 24hr Cd | 24 | $4,123 | $172 |
| Digoxin | 72 | $3,683 | $51 |
| Brilinta | 14 | $3,611 | $258 |
| Digox | 79 | $3,057 | $39 |
| Metoprolol | 92 | $2,850 | $31 |
| Warfarin | 231 | $2,711 | $12 |
| Potassium Chloride | 74 | $2,591 | $35 |
| Valsartan | 12 | $2,476 | $206 |
| Clopidogrel | 74 | $2,420 | $33 |
| Vytorin | 12 | $2,233 | $186 |
| Niacin Er | 11 | $2,176 | $198 |
| Carvedilol | 234 | $2,061 | $9 |
| Meprobamate | 12 | $1,482 | $123 |
| Lisinopril | 122 | $1,161 | $10 |
| Diltiazem Er | 42 | $1,138 | $27 |
| Toprol Xl | 14 | $1,107 | $79 |
| Simvastatin | 117 | $1,082 | $9 |
| Flecainide Acetate | 38 | $1,043 | $27 |
| Labetalol | 25 | $990 | $40 |
| Hydrocodone-Acetaminophen | 20 | $980 | $49 |
| Furosemide | 221 | $965 | $4 |
| Etodolac | 13 | $875 | $67 |
| Valsartan-Hydrochlorothiazide | 16 | $779 | $49 |
| Amlodipine Besylate | 86 | $764 | $9 |
| Synthroid | 11 | $681 | $62 |
| Propranolol Hcl Er | 13 | $626 | $48 |
| Pravastatin | 21 | $623 | $30 |
| Bumetanide | 13 | $579 | $45 |
| Metolazone | 17 | $560 | $33 |
| Lansoprazole | 13 | $555 | $43 |
| Isosorbide Mononitrate Er | 35 | $534 | $15 |
| Hydralazine | 20 | $446 | $22 |
| Losartan | 51 | $441 | $9 |
| Pantoprazole | 32 | $430 | $13 |
| Escitalopram | 15 | $418 | $28 |
| Metoprolol | 52 | $391 | $8 |
| Nifedipine Er | 12 | $300 | $25 |
| Levothyroxine | 14 | $265 | $19 |
| Hydrochlorothiazide | 33 | $261 | $8 |
| Nitrostat | 18 | $239 | $13 |
| Atenolol | 28 | $218 | $8 |
| Propranolol | 28 | $213 | $8 |
| Tamsulosin | 11 | $208 | $19 |
| Spironolactone | 18 | $201 | $11 |
| Diltiazem | 13 | $189 | $15 |
| Metformin | 30 | $176 | $6 |
| Pacerone | 14 | $165 | $12 |
| Klor-Con 8 | 11 | $163 | $15 |
| Sotalol | 12 | $137 | $11 |
| Lorazepam | 22 | $118 | $5 |
| Zolpidem | 21 | $117 | $6 |
| Benazepril | 11 | $95 | $9 |
| Clonidine | 15 | $82 | $5 |
| Lovastatin | 12 | $66 | $5 |
2013: 46 drugs
| Xarelto | 42 | $15,704 | $374 |
| Crestor | 46 | $11,250 | $245 |
| Pradaxa | 24 | $7,972 | $332 |
| Propafenone | 26 | $6,144 | $236 |
| Diovan | 28 | $5,715 | $204 |
| Clopidogrel | 68 | $5,073 | $75 |
| Atorvastatin | 178 | $4,436 | $25 |
| Diltiazem 24hr Er | 45 | $3,941 | $88 |
| Eliquis | 13 | $3,277 | $252 |
| Warfarin | 207 | $2,458 | $12 |
| Carvedilol | 217 | $2,437 | $11 |
| Metoprolol | 67 | $2,396 | $36 |
| Toprol Xl | 15 | $1,770 | $118 |
| Potassium Chloride | 33 | $1,089 | $33 |
| Simvastatin | 87 | $1,078 | $12 |
| Digox | 88 | $1,064 | $12 |
| Amlodipine Besylate | 76 | $1,010 | $13 |
| Valsartan-Hydrochlorothiazide | 13 | $971 | $75 |
| Lisinopril | 102 | $928 | $9 |
| Amiodarone | 51 | $832 | $16 |
| Doxazosin Mesylate | 12 | $742 | $62 |
| Furosemide | 157 | $730 | $5 |
| Lansoprazole | 11 | $666 | $61 |
| Etodolac | 17 | $625 | $37 |
| Pantoprazole | 32 | $604 | $19 |
| Metolazone | 19 | $534 | $28 |
| Propranolol | 34 | $533 | $16 |
| Diltiazem Er | 16 | $528 | $33 |
| Losartan | 32 | $431 | $13 |
| Isosorbide Mononitrate Er | 39 | $420 | $11 |
| Metoprolol | 34 | $396 | $12 |
| Digoxin | 46 | $388 | $8 |
| Carbidopa-Levodopa | 11 | $376 | $34 |
| Spironolactone | 32 | $294 | $9 |
| Atenolol | 31 | $271 | $9 |
| Ramipril | 13 | $251 | $19 |
| Flecainide Acetate | 15 | $245 | $16 |
| Lorazepam | 29 | $236 | $8 |
| Hydrochlorothiazide | 46 | $232 | $5 |
| Klor-Con 8 | 12 | $173 | $14 |
| Enalapril Maleate | 13 | $173 | $13 |
| Hydrocodone-Acetaminophen | 14 | $135 | $10 |
| Metformin | 15 | $125 | $8 |
| Levothyroxine | 12 | $120 | $10 |
| Clonidine | 14 | $100 | $7 |
| Lovastatin | 11 | $63 | $6 |
Money from drug and device companies
$2,346 in 2025
| 2025 | 14 | 66 | None | $2,346 |
| 2024 | 12 | 58 | None | $1,485 |
| 2023 | 10 | 30 | None | $1,189 |
| 2022 | 10 | 27 | None | $1,264 |
| 2021 | 8 | 40 | None | $1,315 |
| 2020 | 5 | 10 | None | $227 |
| 2019 | 7 | 28 | None | $999 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $601 | 18 payments
|
| Abiomed | None | $461 | 5 payments
|
| Medtronic | Onyx Frontier | $459 | 16 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $278 | 10 payments
|
| Biotronik | Solia | $141 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $71 | 3 payments
|
See all 66 published payments
| Medtronic | Meals · 2025-12-24 | Ffrangio | $8 |
| Medtronic | Meals · 2025-12-18 | Onyx Frontier | $25 |
| Medtronic | Meals · 2025-12-17 | Onyx Frontier | $4 |
| Medtronic | Meals · 2025-12-11 | Ffrangio | $21 |
| Edwards Lifesciences | Meals · 2025-12-09 | Sapien 3 Ultra Resilia | $22 |
| Medtronic | Meals · 2025-12-03 | Onyx Frontier | $128 |
| Stryker | Meals · 2025-12-02 | Revcore Thrombectomy Catheter | $47 |
| Medtronic | Meals · 2025-12-01 | Onyx Frontier | $23 |
| Medtronic | Meals · 2025-12-01 | Onyx Frontier | $13 |
| Edwards Lifesciences | Meals · 2025-11-25 | Sapien 3 Ultra Resilia | $35 |
| Medtronic | Meals · 2025-11-20 | Onyx Frontier | $14 |
| Medtronic | Meals · 2025-11-20 | Onyx Frontier | $8 |
| Reflow Medical | Meals · 2025-11-20 | None | $21 |
| Boston Scientific | Meals · 2025-11-11 | General - Brady | $7 |
| Edwards Lifesciences | Meals · 2025-11-11 | Sapien 3 Ultra Resilia | $21 |
| Abiomed | Meals · 2025-11-06 | None | $33 |
| Boston Scientific | Meals · 2025-10-31 | Emblem Mri S-Icd | $9 |
| Abiomed | Meals · 2025-10-21 | None | $134 |
| Novartis Pharmaceuticals | Meals · 2025-10-17 | Leqvio | $33 |
| Boston Scientific | Meals · 2025-10-14 | Accolade Sr | $18 |
| Edwards Lifesciences | Meals · 2025-10-14 | Sapien 3 Ultra Resilia | $54 |
| Abiomed | Meals · 2025-10-13 | None | $31 |
| Philips North America | Meals · 2025-10-07 | Angio Ifr | $14 |
| Medtronic | Meals · 2025-09-09 | Onyx Frontier | $21 |
| Boston Scientific | Meals · 2025-08-26 | Ingevity+ | $29 |
| Boston Scientific | Meals · 2025-08-17 | Ingevity+ | $22 |
| Boston Scientific | Meals · 2025-08-17 | Accolade Sr | $17 |
| Abiomed | Meals · 2025-08-12 | None | $119 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-08-06 | Lifevest | $24 |
| Edwards Lifesciences | Meals · 2025-08-05 | Sapien 3 Ultra Resilia | $22 |
| Medtronic | Meals · 2025-07-29 | Onyx Frontier | $6 |
| Boston Scientific | Meals · 2025-07-22 | Accolade Sr | $23 |
| Boston Scientific | Meals · 2025-07-21 | Lux-Dx Insertable Cardiac Monitor | $23 |
| Edwards Lifesciences | Meals · 2025-07-15 | Sapien 3 Ultra Resilia | $36 |
| Shockwave Medical | Meals · 2025-07-10 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $24 |
| Boston Scientific | Meals · 2025-06-23 | General - Brady | $22 |
| Edwards Lifesciences | Meals · 2025-06-18 | Sapien 3 Ultra Resilia | $23 |
| Abbott Laboratories | Meals · 2025-06-12 | Aveir | $56 |
| Boston Scientific | Meals · 2025-06-03 | Lux-Dx Insertable Cardiac Monitor | $109 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-05-22 | Lifevest | $25 |
| Biotronik | Meals · 2025-05-22 | Acticor 7 Vr-T Dx | $9 |
| Biotronik | Meals · 2025-05-21 | Amvia Edge | $21 |
| Boston Scientific | Meals · 2025-05-16 | General - Brady | $26 |
| Boston Scientific | Meals · 2025-05-14 | General - Brady | $20 |
| Edwards Lifesciences | Meals · 2025-05-13 | Sapien 3 Ultra Resilia | $27 |
| Medtronic | Meals · 2025-05-09 | Hawkone | $9 |
| Shockwave Medical | Meals · 2025-05-02 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $18 |
| Boston Scientific | Meals · 2025-04-17 | General - Therapies | $28 |
| Medtronic | Meals · 2025-04-16 | In.Pact Admiral | $25 |
| Edwards Lifesciences | Meals · 2025-04-15 | Sapien 3 Ultra Resilia | $18 |
| Boston Scientific | Meals · 2025-04-08 | General - Brady | $19 |
| Boston Scientific | Meals · 2025-04-01 | Mylux Patient Kit With Mobile Device | $23 |
| Novartis Pharmaceuticals | Meals · 2025-03-31 | Leqvio | $26 |
| CVRx | Meals · 2025-03-25 | Barostim Neo System | $41 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-03-13 | Lifevest | $22 |
| Abiomed | Meals · 2025-03-12 | None | $143 |
| Boston Scientific | Meals · 2025-03-12 | Lux-Dx Insertable Cardiac Monitor | $50 |
| Biotronik | Meals · 2025-03-12 | Solia | $111 |
| Terumo Medical | Meals · 2025-03-04 | Metacross Otw | $23 |
| Reflow Medical | Meals · 2025-02-27 | None | $32 |
| Medtronic | Meals · 2025-02-21 | Onyx Frontier | $33 |
| Edwards Lifesciences | Meals · 2025-02-11 | Sapien 3 Ultra Resilia | $20 |
| Medtronic | Meals · 2025-01-29 | Onyx Frontier | $14 |
| Medtronic | Meals · 2025-01-27 | Aurora Ev-Icd Mri Surescan | $106 |
| Boston Scientific | Meals · 2025-01-21 | Accolade Sr | $13 |
| Boston Scientific | Meals · 2025-01-13 | General - Therapies | $142 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,485
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $427 | 12 payments
|
| Janssen Pharmaceuticals | Xarelto | $225 | 13 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $160 | 7 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $129 | 6 payments
|
| CVRx | Barostim Neo System | $113 | 5 payments
|
| Medtronic | Onyx Frontier | $99 | 5 payments
|
| Abiomed | Impella | $95 | 1 payment
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $74 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $60 | 2 payments
|
| Philips North America | (Bq9) Coronary Ivus | $42 | 2 payments
|
| Cardiac Dimensions | None | $32 | 1 payment
|
| Biotronik | Acticor 7 Vr-T Dx | $31 | 1 payment
|
2023: $1,189
| Abiomed | Impella | $257 | 2 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $194 | 7 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $172 | 3 payments
|
| Medtronic | Micra | $171 | 3 payments
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $138 | 5 payments
|
| Novo Nordisk | Ozempic | $128 | 3 payments
|
| Philips Electronics North America | (6585) Omniwire | $54 | 3 payments
|
| Biotronik | Edora 8 Dr-T | $50 | 2 payments
|
| Terumo Medical | Heartrail | $16 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $9 | 1 payment
|
2022: $1,264
| Boston Scientific | Watchman Access System | $537 | 8 payments
|
| Abiomed | Impella | $303 | 4 payments
|
| Medtronic | Linq II | $97 | 1 payment
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $79 | 2 payments
|
| Abbott Laboratories | Optis | $73 | 3 payments
|
| Novartis Pharmaceuticals | Leqvio | $61 | 4 payments
|
| Biotronik | Biomonitor | $49 | 2 payments
|
| Bard Peripheral Vascular | Venovo | $22 | 1 payment
|
| Getinge USA Sales | Cardiosave Hybrid, Type B Plug | $22 | 1 payment
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $21 | 1 payment
|
2021: $1,315
| Boston Scientific | Watchman | $610 | 13 payments
|
| Abiomed | Impella | $269 | 7 payments
|
| Biotronik | Edora | $230 | 7 payments
|
| Medtronic | Telescope | $115 | 8 payments
|
| Abbott Laboratories | Xience Sierra Coronary Stent | $51 | 2 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $14 | 1 payment
|
| Getinge USA Sales | Vasoview Hemopro 2 | $14 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $12 | 1 payment
|
2020: $227
| Medtronic Vascular | Micra | $62 | 2 payments
|
| Boston Scientific | Ingevity | $58 | 3 payments
|
| Biotronik | None | $51 | 3 payments
|
| Penumbra | Indigo | $33 | 1 payment
|
| Philips Electronics North America | Igt D Coronary | $23 | 1 payment
|
2019: $999
| Boston Scientific | Latitude | $455 | 9 payments
|
| Abbott Laboratories | Optis Coronary Imaging System | $199 | 7 payments
|
| Biotronik | None | $149 | 6 payments
|
| Medtronic Vascular | Resolute | $144 | 2 payments
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $20 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $18 | 2 payments
|
| Roche Diagnostics | Cd Cobas Reagents | $15 | 1 payment
|
Professional record
- NPI
- 1134257702
- Licence
- CA A90330California A90330: Current · expires 2027-03-31
- Trained
- University of California, San Diego School of Medicine, 2003
- Group
- University Healthcare Alliance · Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 5565 W Las Positas Blvd Ste 150, Pleasanton, CA, 94588
- NPI first listed
- 2007-03-02
- NPI last updated
- 2024-04-24
- NPI record certified
- 2024-04-24
This is when the NPI record was last certified, not a medical board exam.